Hereditary Hemochromatosis
📧 Sign up to get email alerts when something new happens for Hereditary Hemochromatosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: Efficacy and Safety of Vamifeport in Adult Participants With Homeostatic Iron Regulator Gene (HFE)-Related Hereditary Hemochromatosis [Phase 2]
A Phase 2 clinical trial evaluating the efficacy and safety of vamifeport in adults with HFE-related hereditary hemochromatosis, currently r…
-
CLINICAL_TRIALS trial_result · 2026-01-28Clinical Trial Update: A Study to Evaluate BBI-001 in Healthy Volunteers and in Patients With Hereditary Hemochromatosis [Phase 1, Phase 2]
An early-stage study evaluating BBI-001 in healthy volunteers and patients with hereditary hemochromatosis across Phase 1 and Phase 2, not y…
-
CLINICAL_TRIALS trial_result · 2024-06-07Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Deferasirox Film-coated Tablet Versus Phlebotomy in Patients With Hereditary Hemochromatosis (HH) [Phase 2]
Phase 2 study evaluating deferasirox film-coated tablet versus phlebotomy in hereditary hemochromatosis was terminated, and results have bee…
-
CLINICAL_TRIALS trial_result · 2024-05-03Clinical Trial Update: Cardiac Function in Patients With Hereditary Hemochromatosis
This clinical trial update reports cardiac function outcomes from a completed study in patients with hereditary hemochromatosis.
-
CLINICAL_TRIALS trial_result · 2023-06-15Clinical Trial Update: PTG-300 in Subjects With Hereditary Hemochromatosis [Phase 2]
Phase 2 study of PTG-300 for hereditary hemochromatosis has completed and results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-06-09Clinical Trial Update: A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis [Phase 2]
Phase 2 clinical trial of LJPC-401 for iron overload in hereditary hemochromatosis completed; results posted in 2022.
-
CLINICAL_TRIALS trial_result · 2017-10-20Clinical Trial Update: Estimation of Myocardial Iron Overload by 3 Tesla MRI in HFE Hereditary Haemochromatosis [NA]
A completed clinical trial evaluating estimation of myocardial iron overload using 3 Tesla MRI in patients with HFE-associated hereditary he…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Respiratory Variations For Assessing Blood Withdrawal
The clinical trial NCT03066414 conducted by University Hospital Lille has completed a study investigating respiratory variations for assessi…
-
CLINICAL_TRIALS trial_result · 2017-01-31Clinical Trial Update: Safety and Efficacy of Iron Reduction by Phlebotomy [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of reducing iron levels by phlebotomy in patients with iron overload; study comple…
-
CLINICAL_TRIALS trial_result · 2016-09-27Clinical Trial Update: Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary? [NA]
A completed clinical trial evaluating Mi-iron for hereditary hemochromatosis to determine whether reducing iron overload is necessary.
-
CLINICAL_TRIALS trial_result · 2015-05-27Clinical Trial Update: Bone Status on Patients With Genetic Hemochromatosis: a 3 Years Descriptive and Evolutionary Study
This is a completed three-year descriptive and evolutionary study assessing bone status in patients with hereditary hemochromatosis.
-
CLINICAL_TRIALS trial_result · 2015-03-10Clinical Trial Update: Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.
A Rennes University Hospital-sponsored trial investigating rare iron overload disorders excluding C282Y homozygosity has been terminated; th…
-
CLINICAL_TRIALS trial_result · 2014-07-24Clinical Trial Update: HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
The HEPFER trial evaluating a new phenotypic biological marker in genetic-type 1 hereditary hemochromatosis has completed.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients [Phase 3]
A Phase 3 clinical trial update comparing erythrocytapheresis to phlebotomy as maintenance therapy in hereditary hemochromatosis.
-
CLINICAL_TRIALS research · 2012-02-02Clinical Trial Update: Proton Pump Inhibitors in the Prevention of Iron Reaccumulation in Patient With Hereditary Hemochromatosis [NA]
This clinical trial update notes an ongoing study at Maastricht University Medical Center evaluating whether proton pump inhibitors can prev…
-
CLINICAL_TRIALS trial_result · 2011-05-18Clinical Trial Update: Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis [Phase 1, Phase 2]
Phase 1/2 clinical trials evaluated the safety and efficacy of Deferasirox (ICL670) for iron overload caused by hereditary hemochromatosis, …
-
CLINICAL_TRIALS trial_result · 2007-03-01Clinical Trial Update: Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis [Phase 2, Phase 3]
Completed Phase 2/3 clinical trial comparing phlebotomy versus erythrocytapheresis for management of hereditary hemochromatosis.